Maravai Lifesciences Holdings, Inc. (MRVI)
2.86
-0.23
(-7.44%)
USD |
NASDAQ |
Mar 27, 16:00
2.855
0.00 (0.00%)
After-Hours: 20:00
Maravai Lifesciences Holdings Profit Margin (Quarterly) : -126.4% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 13.43% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| MiMedx Group, Inc. | 12.86% |
| ADMA Biologics, Inc. | 35.48% |
| Arcus Biosciences, Inc. | -321.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.48% |
| Return on Assets | -25.73% |
| Return on Invested Capital | -27.56% |
| Gross Profit Margin (Quarterly) | 24.55% |
| Operating Margin (Quarterly) | -13.51% |
| Return on Net Operating Assets | -39.71% |